Navigation Links
LSTM to lead EU project to coordinate antimalarial drug research
Date:8/20/2009

The European Commission is funding a two year, 500,000 project to co-ordinate European and international research into the development of new drugs to treat malaria.

The CRIMALDDI project (Coordination, Rationalisation and Integration of Antimalarial Drug Discovery and Development Initiatives) is being led by the Liverpool School of Tropical Medicine (LSTM) and brings together key players in the antimalarial drug discovery fields including the World Health Organisation, the Medicines for Malaria Venture (MMV) and leading research organisations across Europe.

Professor Steve Ward, Deputy Director of LSTM and Scientific Coordinator of the CRIMALDDI project explained: "New drugs to prevent, treat and eventually eliminate malaria are desperately needed if we are to make an impact upon the millions needlessly dying from this disease each year. Antimalarial drug research and development (R&D) programmes are in operation across Europe and throughout the world, but too often these initiatives are uncoordinated and time and money is spent going over old ground."

CRIMALDDI will address this by assessing research in Europe and internationally. It will develop a prioritised roadmap for antimalarial drug discovery efforts in Europe and a 5-year action plan to deliver on this roadmap. An expert advisory group will provide external validation and ensure that the plans are practical and appropriate. CRIMALDDI will also seek to formulate strategies to ensure better co-ordination of R&D, remove barriers to drug development and facilitate the dissemination of results.

Tim Wells, CSO for MMV said "CRIMALDDI is a timely initiative. It makes a great deal of sense to coordinate efforts globally so that researchers know exactly what is going on in this field and do not run the risk of duplicating efforts. With limited resources available for antimalarial drug R&D, time, funding and expertise are too precious to waste."

Commenting on the project, Professor Ward said: "Co-ordinating research will mean that resources are better directed towards the faster development of new drugs to treat and eliminate malaria. We will look at the global status of antimalarial drug discovery and use that information to ensure that the research agenda for antimalarials in Europe over the next decade is properly aligned with what's going on elsewhere in the world."


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpool School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. QI projects may -- or may not -- improve patient safety and outcomes
2. MU researchers to collaborate on $20 million project
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Jacobs Receives Contract for New Hospital Project in Belgium
5. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
6. Global Health Project targets reducing AIDS among Indias adolescents
7. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
8. New Business Development of Multi-Hospital Project!
9. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
10. Meth Project Advertisements Selected for National Prevention Campaign
11. Pillow, PAs Great American Sleep Better(TM)Project Reports Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/12/2017)... Oct. 12, 2017 West Pharmaceutical Services, ... solutions for injectable drug administration, today announced that it ... opens on Thursday, October 26, 2017, and will follow ... business expectations at 9:00 a.m. Eastern Time. To participate ... (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology: